Literature DB >> 8256775

Use of the positive predictive value to correct for disease misclassification in epidemiologic studies.

H Brenner1, O Gefeller.   

Abstract

Misclassification problems of the disease status often arise in large epidemiologic cohort studies in which the outcome is classified on the basis of record linkage with routinely collected error-prone data sources, such as cancer registries or mortality statistics. If the misclassification is nondifferential, i.e., independent of the exposure status, this leads to bias toward the null in estimates of relative risk. A variety of methods have been proposed to correct for this bias. Most approaches are based on estimates of the sensitivity and specificity of disease classification from validation studies, which typically require invasive and time-consuming diagnostic procedures. For ethical and practical reasons, such procedures may often not be applied on individuals classified as not having the disease, in which case estimates of sensitivity and specificity cannot be obtained. In this paper, an alternative correction method is proposed based on estimates of the positive predictive value, which requires validation of the diagnosis among samples of individuals classified as having the disease only. The method is applicable in situations with either differential or nondifferential specificity of disease classification as long as the sensitivity is nondifferential. Point estimates and large-sample interval estimates of the corrected relative risk are algebraically derived. The performance of the method is assessed by extensive simulations and found to be satisfactory even for small sample sizes.

Entities:  

Mesh:

Year:  1993        PMID: 8256775     DOI: 10.1093/oxfordjournals.aje.a116805

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  27 in total

1.  Problems in using incidence to analyze risk factors in follow-up studies.

Authors:  J Pekkanen; J Sunyer
Journal:  Eur J Epidemiol       Date:  2008-08-14       Impact factor: 8.082

2.  Reducing bias from test misclassification in burden of disease studies: use of test to actual positive ratio--new test parameter.

Authors:  Harry Campbell; Zrinka Biloglav; Igor Rudan
Journal:  Croat Med J       Date:  2008-06       Impact factor: 1.351

3.  Regression Analysis for Differentially Misclassified Correlated Binary Outcomes.

Authors:  Li Tang; Robert H Lyles; Caroline C King; Joseph W Hogan; Yungtai Lo
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2015-04       Impact factor: 1.864

Review 4.  A primer on quantitative bias analysis with positive predictive values in research using electronic health data.

Authors:  Sophia R Newcomer; Stan Xu; Martin Kulldorff; Matthew F Daley; Bruce Fireman; Jason M Glanz
Journal:  J Am Med Inform Assoc       Date:  2019-12-01       Impact factor: 4.497

5.  [Vertebral deformity as an index of osteoporosis-induced spinal fracture--an external validity construct based on bone density data].

Authors:  C Scheidt-Nave; D Felsenberg; G Kragi; T Bruckner; G Leidig-Bruckner; C Wüster; R Ziegler
Journal:  Med Klin (Munich)       Date:  1998-03-15

6.  The impact of hip and knee osteoarthritis on the subsequent risk of incident diabetes: a population-based cohort study.

Authors:  Tetyana Kendzerska; Lauren K King; Lorraine Lipscombe; Ruth Croxford; Ian Stanaitis; Gillian A Hawker
Journal:  Diabetologia       Date:  2018-08-08       Impact factor: 10.122

7.  Evaluation of algorithms to identify delirium in administrative claims and drug utilization database.

Authors:  Dae Hyun Kim; Jung Lee; Caroline A Kim; Krista F Huybrechts; Brian T Bateman; Elisabetta Patorno; Edward R Marcantonio
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-05-09       Impact factor: 2.890

8.  Bias from outcome misclassification in immunization schedule safety research.

Authors:  Sophia R Newcomer; Martin Kulldorff; Stan Xu; Matthew F Daley; Bruce Fireman; Edwin Lewis; Jason M Glanz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-01-02       Impact factor: 2.890

9.  Testosterone Therapy in Relation to Prostate Cancer in a U.S. Commercial Insurance Claims Database.

Authors:  Michael B Cook; Daniel C Beachler; Lauren E Parlett; Philip T Cochetti; William D Finkle; Stephan Lanes; Robert N Hoover
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10-22       Impact factor: 4.254

10.  ERROR-FREE MILESTONES IN ERROR PRONE MEASUREMENTS.

Authors:  Dylan S Small; Paul R Rosenbaum
Journal:  Ann Appl Stat       Date:  2009       Impact factor: 2.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.